Genomma Lab Internacional. de Dividends and Buybacks
Dividend criteria checks 3/6
Genomma Lab Internacional. de is a dividend paying company with a current yield of 3.08% that is well covered by earnings.
Key information
3.1%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 3.4% |
| Future Dividend Yield | 2.8% |
| Dividend Growth | 14.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.0438 |
| Payout ratio | 12% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, GNML.F has been paying a dividend for less than 10 years.
Growing Dividend: GNML.F's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Genomma Lab Internacional. de Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GNML.F) | 3.1% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (GNML.F) (up to 3 years) | 2.8% |
Notable Dividend: GNML.F's dividend (3.08%) is higher than the bottom 25% of dividend payers in the US market (1.35%).
High Dividend: GNML.F's dividend (3.08%) is low compared to the top 25% of dividend payers in the US market (4.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (11.6%), GNML.F's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.5%), GNML.F's dividend payments are well covered by cash flows.